Lido Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.3M Buy
323,507
+17,456
+6% +$1.6M 0.09% 152
2025
Q4
$29.9M Sell
306,051
-8,246
-3% -$782K 0.09% 148
2025
Q3
$31M Buy
314,297
+41,210
+15% +$4.08M 0.1% 136
2025
Q2
$25M Buy
273,087
+251,965
+1,193% +$24.4M 0.1% 129
2025
Q1
$2.4M Sell
21,122
-2,667
-11% -$285K 0.01% 500
2024
Q4
$2.52M Buy
23,789
+248
+1% +$26.6K 0.01% 472
2024
Q3
$2.54M Sell
23,541
-772
-3% -$84.3K 0.01% 421
2024
Q2
$2.64M Sell
24,313
-11
-0% -$1.3K 0.01% 396
2024
Q1
$3.22M Buy
24,324
+2,694
+12% +$337K 0.02% 341
2023
Q4
$2.64M Sell
21,630
-84
-0.4% -$9.37K 0.02% 359
2023
Q3
$2.44M Sell
21,714
-351
-2% -$44.6K 0.02% 337
2023
Q2
$3.21M Sell
22,065
-307
-1% -$41.7K 0.02% 288
2023
Q1
$2.89M Sell
22,372
-11,378
-34% -$1.43M 0.03% 276
2022
Q4
$4.3M Buy
33,750
+14,429
+75% +$1.67M 0.05% 184
2022
Q3
$2.02M Buy
19,321
+14,374
+291% +$1.58M 0.03% 267
2022
Q2
$519K Buy
4,947
+1,359
+38% +$161K 0.01% 530
2022
Q1
$458K Buy
3,588
+1,747
+95% +$211K 0.01% 629
2021
Q4
$227K Buy
+1,841
New +$241K ﹤0.01% 922
2021
Q2
Sell
-2,775
Closed -$432K 958
2021
Q1
$432K Sell
2,775
-1,587
-36% -$246K 0.01% 545
2020
Q4
$653K Buy
4,362
+1,513
+53% +$214K 0.01% 414
2020
Q3
$377K Buy
+2,849
New +$372K 0.01% 434

Other funds holding ZBH

Lido Advisors's ZBH Position: Q1 2026 in Review

Lido Advisors increased its Zimmer Biomet (ZBH) stake by 5.7% in Q1 2026, buying an estimated $1.6M and bringing the position to 323,507 shares worth $29.3M. The position accounts for 0.09% of the portfolio, ranked #152.

Lido Advisors first reported a position in ZBH in Q3 2020 and has held it in 21 quarters since. The position peaked at $31M in Q3 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Lido Advisors held 323,507 shares of Zimmer Biomet worth $29.3M as of Q1 2026.
  • Lido Advisors bought 17,456 Zimmer Biomet shares in Q1 2026, an estimated $1.6M.
  • Zimmer Biomet made up 0.09% of Lido Advisors's portfolio in Q1 2026, its #152 holding.
  • Lido Advisors first reported a position in Zimmer Biomet in Q3 2020 and has held it in 21 quarters since.
  • Lido Advisors's Zimmer Biomet position peaked at $31M in Q3 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.